Reviewed the eleven assigned functional annotations from saved sources. Eight positive localization/coat/endocytosis/AP-2-binding annotations are accepted; T-cell signaling and positive activation are retained as non-core contexts. The inherited negated coated-vesicle annotation remains UNDECIDED, with its NOT flag unchanged. The full source-keyed reviews and stable article locators are in the functional decision table and source guide.
The 2010 original and supplement were recovered before this static continuation. The linked Expression of Concern and later Erratum are verified editorial records, but their bodies, affected-experiment scope and resolution are unavailable. The complete reference assessment preserves that uncertainty. Independent human FCHO1 evidence from 2012 and 2020 supports the positive functional claims without universal-nucleator language.
The earlier genuine research-provider attempts failed and produced no research report. No provider report has been fabricated or substituted. The interrupted evidence-gathering directory and its recovery handoff remain unchanged. This continuation used only saved evidence and added no acquisition, experiment proposal, NEW annotation, supporting quotation or natural-product assertion. The seven interaction reviews and database reviews are separate assignments. Their partial status does not imply a negative scientific conclusion.
The separately recovered 2020 Author Correction (PMID:32312977) was read before finalizing this lane. Its correction of the Discussion’s description of prior work and transferrin-receptor context is incorporated into the complete reference assessments and source guide. The eleven annotation decisions are unchanged, and the original article cache remains exact.